FDA enforcement record
Unapproved New Drugs Sold Over the Internet
Published Apr 7, 2026 · Public FDA record · Mile High Compounds LLC
- Recipient: Mile High Compounds LLC
- Date: Apr 7, 2026
Why this record matters
FDA warning letters are public enforcement actions: they flag significant violations, often precede import alerts or deeper enforcement, and are read closely by customers, suppliers and competitors. For how to interpret one — and how a Form 483 escalates into a letter — see our 483 vs warning letter guide and the 15-day response playbook.
Get new FDA warning letters the day they publish
Daily Telegram or email briefs — device, drug and food streams. Free tier available.
Latest letters
- CGMP/QSR/Medical Devices/Adulterated · Nov 3, 2026
- Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k) · Oct 27, 2026
- Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) · Oct 27, 2026
- CGMP/QSR/Medical Devices/Adulterated · Oct 27, 2026
- CGMP/QSR/Medical Devices/Adulterated · Oct 20, 2026
- CGMP/QSR/Medical Devices/Adulterated · Oct 6, 2026